Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.80 -0.09 (-3.11%)
As of: Oct 1, 2026 · 11:38 AM EDT

Kalaris Therapeutics (KLRS) Accounts Payables (2019 - 2026)

Updated

Kalaris Therapeutics (KLRS) reported Accounts Payables of $1.12 million for Q2 2026, down 69.5% from $3.68 million a year earlier but up 24.2% from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Accounts Payables (2019 - 2026) Analysis & Trends

At the end of FY2025, Kalaris Therapeutics posted Accounts Payables of $1.28 million, down 17.9% from FY2024.

  • Accounts Payables has a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
  • By year, Accounts Payables came in at $1.56 million in FY2024 (-76.9%), $6.76 million in FY2023 (+125.1%), $3 million in FY2022 (-64.1%) and $8.36 million in FY2021 (+768.2%).
  • Five-year quarterly Accounts Payables spans a low of $51,000 in Q3 2024 and a high of $8.36 million in Q4 2021.
  • Year over year, Accounts Payables has now declined in each of the last three quarters, with growth averaging 107.7% over the last seven quarters.
  • The high point for year-over-year Accounts Payables in five years was Q3 2025 (growth of 868.6%); the low point was Q3 2024 (a decline of 98.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $905,000 (Q1 2026), $1.28 million (Q4 2025) and $494,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Kalaris Therapeutics 68.80 Mn 68.80 Mn - 1.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.12 Mn
Mar 31, 2026 905,000.00
Dec 31, 2025 1.28 Mn
Sep 30, 2025 494,000.00
Jun 30, 2025 3.68 Mn
Mar 31, 2025 2.37 Mn
Dec 31, 2024 1.56 Mn
Sep 30, 2024 51,000.00
Jun 30, 2024 110,000.00
Mar 31, 2024 765,000.00
Dec 31, 2023 6.76 Mn
Sep 30, 2023 3.93 Mn
Jun 30, 2023 5.16 Mn
Mar 31, 2023 4.13 Mn
Dec 31, 2022 3.00 Mn
Sep 30, 2022 4.89 Mn
Jun 30, 2022 5.52 Mn
Mar 31, 2022 4.47 Mn
Dec 31, 2021 8.36 Mn
Sep 30, 2021 133,000.00
API Access

Kalaris Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=KLRS&period=max&api_key=YOUR_API_KEY